Forbes |
Popis: Forbes - Pharma & Healthcare
|
||||||
Holiday Stress In The Age Of ‘Buy Now, Pay Later’15:38 The holidays can intensify stress and financial pressure. New research shows a link between mental health challenges and the use of Buy Now, Pay Later services. Baby Boomers Are Aging Into A Primary Care Shortage. America Isn’t Ready For This18.prosince The largest influx of new beneficiaries is aging into Medicare amid a worsening clinician shortage. Here are four ways the industry can head off this looming crisis. Five Medical Breakthroughs Of 2025: Cancer, Heart, And Genetic Diseases18.prosince This year saw notable progress in head and neck cancers, Huntington's disease, personalized genetic therapy, and heart disease due to high cholesterol. Start Spreading The News: The Flu Loves New York18.prosince New York City is seeing an early, rapid spike of flu cases. This may not bode well for the season ahead. New $ 1.9 Billion Pledge For Global Polio Eradication Initiative18.prosince A new $1.9 billion pledge to the Global Polio Eradication Initiative was just announced at the “Investing in Humanity: Uniting to End Polio” event in Abu Dhabi. Why Maintaining A Healthy Weight Isn’t The Same For Everyone17.prosince Obesity is not a single disease. New research shows distinct biological phenotypes that explain why weight gain and treatment response vary so widely. The Healthcare Industry Outlook For 202617.prosince In this week’s edition of InnovationRx, we look at French healthtech Doctolib’s potential large secondary round, Alice Schwartz’s legacy at Bio-Rad, and more. Republicans Can Solve The Healthcare Crisis—And Win Politically17.prosince A number of Republicans are currently comatose when it comes to pushing positive healthcare policies. Here’s how they can overcome this. Why We Should Be Talking About Heat As The Weather Cools16.prosince Extreme heat is the deadliest weather-related threat in the U.S., and important decisions to prevent it are made when temperatures are cold. Why planning now matters. French Health Tech Unicorn Plans Secondary Investment Of Hundreds Of Millions16.prosince Doctolib, once France’s most valuable startup, was worth $6.4 billion at its previous funding round in 2022. Chaos At The FDA Benefits America’s Rivals—At The Expense Of America’s Patients15.prosince If the FDA ceases to be a predictable source of regulatory guidance, then China will gain a significant advantage in the race for biopharmaceutical supremacy. How AI Will Reshuffle Healthcare: A Conversation With Sangeet Choudary15.prosince In this conversation with business strategist Sangeet Paul Choudary, we explore how AI will reshape healthcare delivery—and what other industries can teach us. |